Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ribavirin Pregnancy Registry

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by INC Research
Sponsor:
Collaborators:
Aurobindo Pharma
Genentech, Inc.
Sandoz
Merck Sharp & Dohme Corp.
Teva Pharmaceuticals USA
Zydus Pharmaceuticals USA, Inc.
Kadmon Corporation, LLC
Information provided by (Responsible Party):
INC Research
ClinicalTrials.gov Identifier:
NCT00114712
First received: June 16, 2005
Last updated: August 29, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2025
  Estimated Primary Completion Date: December 2024 (Final data collection date for primary outcome measure)